A Study of SGN-STNV in Advanced Solid Tumors
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
a study on Lung Cancer Non-Small Cell Lung Cancer Breast Cancer Ovarian Cancer Cervical Cancer Endometrial Cancer Esophageal Cancer Gastroesophageal Junction Cancer Stomach Cancer Colorectal Cancer Colorectal Tumor Pancreatic Cancer Appendiceal Adenocarcinoma Pseudomyxoma Peritonei Solid Tumor
Carcinoma, Non-Small Cell Lung, HER2 Negative Breast Neoplasms, Ovarian Neoplasms, Uterine Cervical Neoplasms, Endometrial Neoplasms, Esophageal Neoplasms, Gastroesophageal Junction Carcinoma, Stomach Neoplasms, Colorectal Neoplasms, Exocrine Pancreatic Adenocarcinoma, Appendiceal Adenocarcinoma, Pseudomyxoma Peritonei, NSCLC, Non-Small Cell Lung Cancer, HER2-Negative Breast Cancer, High-Grade Serous Ovarian Cancer, HGSOC, Ovarian Cancer, Cervical Cancer, Endometrial Cancer, Esophageal Cancer, Gastric Cancer, GEJ Carcinoma, Colorectal Cancer, Seattle Genetics, Carcinoma, Neoplasms, Adenocarcinoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, SGN-STNV
Lead Scientist at University of California Health
- Pamela Munster (ucsf)
Professor, Medicine, School of Medicine. Authored (or co-authored) 140 research publications
- accepting new patients
- Start Date
- Completion Date
- Seagen Inc.
- Phase 1 research study
- Study Type
- Expecting 315 study participants
- Last Updated